Skip to content
value.today

FORE US Bio Inc.

Total raised
$132 M
2 rounds on record
Latest round
$70 M
Apr 2025
First round on record
Aug 2023
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of FORE US Bio Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2025$70 MNo. 2$50 to $250 million

FORE US Bio Inc.: Raise no. 2, Apr 2025

Investors in this round

20 investors had bought by the notice of Jul 14, 2026: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$70 M of $110 M offered; $39 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Byrnes · Executive Officer · Chief Financial Officer
  • William Hinshaw · Executive Officer, Director
  • Chandra Leo · Director
  • Dieter Weinand · Director
  • Erez Chimovits · Director
  • Giovanni Mariggi · Director
  • Kim Blackwell · Director
  • Rajeev Dadoo · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Byrnes, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 14, 2026. Read the notice at the SEC.

equitySEC
Aug 2023$62 MNo. 1$50 to $250 million

FORE US Bio Inc.: Raise no. 1, Aug 2023

Investors in this round

20 investors had bought by the notice of Aug 24, 2023: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$62 M of $123 M offered; $60 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff Sacher · Executive Officer · Chief Financial Officer
  • Matthew Ros · Executive Officer, Director · Chief Executive Officer, President and Secretary
  • Chandra Leo · Director
  • Dieter Weinand · Director
  • Erez Chimovits · Director
  • Kim Blackwell · Director
  • Matthew Foy · Director
  • Meenu Chhabra Karson · Director
  • Michal Silverberg · Director
  • Roberto De Ponti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$28,629,470.70 of the Total Offering Amount and Total Amount Sold includes principal and interest due on certain instruments convertible or exercisable into equity of the Issuer.”

Signed by Matthew Ros, Ceo. Source: SEC Form D, newest notice filed Aug 24, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • FORE US Bio Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2026).

    SEC Form D · Jul 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2026

That is all the official record says: FORE US Bio Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of FORE US Bio Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 20 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by FORE US Bio Inc.
NameRoleNamed in
Michael ByrnesChief Financial OfficerJul 2026
William HinshawExecutive officerJul 2026
Jeff SacherChief Financial OfficerAug 2023
Matthew RosChief Executive Officer, President and SecretaryAug 2023
Chandra LeoDirectorJul 2026
Dieter WeinandDirectorJul 2026
Erez ChimovitsDirectorJul 2026
Giovanni MariggiDirectorJul 2026
Kim BlackwellDirectorJul 2026
Rajeev DadooDirectorJul 2026
William HinshawDirectorJul 2026
Matthew FoyDirectorMay 2025
Michael ByrnesDirectorMay 2025
Matthew RosChief Executive Officer, President and SecretaryAug 2023
Meenu Chhabra KarsonDirectorAug 2023
Michal SilverbergDirectorAug 2023
Roberto De PontiDirectorAug 2023